Robert E. Ratner, MD, FACP, FACE
Chief Scientific & Medical Officer
Dr. Robert E. Ratner is Chief Scientific & Medical Officer for the American Diabetes Association, the nation’s largest voluntary health organization leading the fight to Stop Diabetes®.
Dr. Ratner provides leadership and oversight of scientific and medical activities including research, clinical affairs, program recognition and certification, medical information and professional education. In this capacity, he oversees the Association's support of a broad range of professional education activities and the development of the American Diabetes Association Clinical Practice Recommendations, clinical consensus reports and expert opinions. In 2011, the Association provided $34.6 million in research funds, funding more than 400 grants at 139 leading U.S. research institutions.
Prior to joining the American Diabetes Association, Dr. Ratner was a Professor of Medicine at Georgetown University Medical School and Senior Research Scientist at the MedStar Health Research Institute in metropolitan Washington, DC. He recently completed a sabbatical as a Robert Wood Johnson Foundation Health Policy Fellow, having served as the study director for the Institute of Medicine Comparative Effectiveness Research Priorities Committee, and a program examiner for health reform in the Health Division of the U.S. Office of Management and Budget.
He received his MD from Baylor College of Medicine in Houston, Texas where he also completed his Internal Medicine training. He underwent fellowship training in Endocrinology and Metabolism at Harvard Medical School and the Joslin Diabetes Center in Boston. He recently completed six years of service on the Steering Committee of the National Diabetes Education Program (NDEP), representing the American Diabetes Association. He has served on the Board of Directors of the National Certification Board for Diabetes Education and the American Association of Diabetes Educators, and is Past-President of the Washington Area Affiliate of the American Diabetes Association. He has served as the Chair of the Government Relations Committee and the Pregnancy Council of the American Diabetes Association.
He is a Principal Investigator for the Diabetes Prevention Program (DPP) and DPP Outcomes Study of the National Institutes of Health (NIH) and serves on the Steering Committee for the project nationwide. At Georgetown University, he served on the University Research Committee, and co-chaired the Joint Oversight Committee for Clinical Research.
He is currently an Associate Editor of the Journal of Clinical Endocrinology and Metabolism. His research interests include diabetes therapeutics and complications, with an emphasis on translational efforts from controlled trials into community-based practice. He is the author of more than 120 original scientific articles and 20 book chapters.